TMS Co., Ltd
4891 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 府中市府中町一丁目９番地京王府中１丁目ビル１１階
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
TMS Co., Ltd is a Japanese company focused on enhancing user experiences through advanced technology solutions. Leveraging innovative digital tools, TMS is dedicated to providing seamless browsing experiences for its clients and visitors. The company emphasizes the importance of user consent and data privacy, implementing cookie policies that ensure transparency in its digital engagements. TMS Co., Ltd strives to maintain high standards of service while adapting to the evolving landscape of technology, aiming to meet the diverse needs of its users effectively. With a commitment to quality and user satisfaction, TMS continues to be a significant player in the tech industry.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-30 03:20 |
Inside Information Statement
臨時報告書
|
Japanese | 27.5 KB | |
| 2025-05-30 03:18 |
Regulatory News Service
確認書
|
Japanese | 7.9 KB | |
| 2025-05-30 03:17 |
Internal Control over Financial Reporting
内部統制報告書－第21期(2024/03/01－2025/02/28)
|
Japanese | 21.1 KB | |
| 2025-05-30 03:15 |
Annual Report
有価証券報告書－第21期(2024/03/01－2025/02/28)
|
Japanese | 2.9 MB | |
| 2025-04-09 09:05 |
Inside Information Statement
臨時報告書
|
Japanese | 19.9 KB | |
| 2025-03-14 07:58 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 407.4 KB | |
| 2025-02-28 07:37 |
Inside Information Statement
臨時報告書
|
Japanese | 18.5 KB | |
| 2025-02-06 09:01 |
Inside Information Statement
臨時報告書
|
Japanese | 19.1 KB | |
| 2024-10-15 08:18 |
Regulatory News Service
確認書
|
Japanese | 7.9 KB | |
| 2024-10-15 08:15 |
Interim Report
半期報告書－第21期(2024/03/01－2025/02/28)
|
Japanese | 176.1 KB | |
| 2024-07-12 08:14 |
Regulatory News Service
確認書
|
Japanese | 7.9 KB | |
| 2024-07-12 08:12 |
Quarterly Report
四半期報告書－第21期第1四半期(2024/03/01－2024/05/31)
|
Japanese | 125.8 KB | |
| 2024-05-29 03:27 |
Regulatory News Service
確認書
|
Japanese | 7.9 KB | |
| 2024-05-29 03:25 |
Internal Control over Financial Reporting
内部統制報告書－第20期(2023/03/01－2024/02/29)
|
Japanese | 21.1 KB | |
| 2024-05-29 03:23 |
Annual Report
有価証券報告書－第20期(2023/03/01－2024/02/29)
|
Japanese | 2.8 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |